- UHRA Home
- Browsing by Author
Browsing by Author "Berg, Jurrien M.ten"
Now showing items 1-2 of 2
-
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Gorog, Diana A.; Storey, Robert F.; Gurbel, Paul A.; Tantry, Udaya S.; Berger, Jeffrey S.; Chan, Mark Y.; Duerschmied, Daniel; Smyth, Susan S.; Parker, William A.E.; Ajjan, Ramzi A.; Vilahur, Gemma; Badimon, Lina; Berg, Jurrien M.ten; Cate, Hugo ten; Peyvandi, Flora; Wang, Taia T.; Becker, Richard C. (2022-07)Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and thromboembolic events, owing to excessive inflammation, endothelial cell activation and injury, platelet activation and hypercoagulability. Patients ... -
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.
Gorog, Diana; Ferreiro, Jose Luis; Ahrens, Ingo; Ako, Junya; Geisler, Tobias; Halvorsen, Sigrun; Huber, Kurt; Jeong, Young-Hoon; Navarese, Eliano P; Rubboli, Andrea; Sibbing, Dirk; Siller-Matula, Jolanta M; Storey, Robert F.; Tan, Jack W C; Berg, Jurrien M.ten; Valgimigli, Marco; Vandenbriele, Christophe; Lip, Gregory Y H (2023-07-20)Conventional dual antiplatelet therapy (DAPT) for patients with acute coronary syndromes undergoing percutaneous coronary intervention comprises aspirin with a potent P2Y purinoceptor 12 (P2Y12) inhibitor (prasugrel or ...